biotech-pitch-deck-narrative

# Biotech Pitch Deck Narrative ## Overview Strategic communication tool that translates complex biotechnology innovations into compelling business narratives optimized for venture capital, pharmaceutical partnerships, and public market investors. **Key Capabilities:** - **Science Translation**: Convert technical data into business value language - **Narrative Architecture**: Structure Problem→Solution→Market→Traction→Vision flow - **Stage Optimization**: Tailor messaging for seed through IPO fundraising - **Investor Calibration**: Adapt for generalist vs. specialist audiences - **Risk Mitigation**: Frame scientific and regulatory risks as manageable challenges - **Q&A Preparation**: Anticipate investor questions and prepare responses ## When to Use **✅ Use this skill when:** - Preparing Series A/B pitch decks for VC presentations - Creating management presentations for IPO roadshows - Developing BD materials for pharma partnership discussions - Crafting executive summaries for grant applications - Rehearsing investor Q&A for earnings calls - Translating clinical data into commercial narratives - Adapting academic presentations for business audiences **❌ Do NOT use when:** - Scientific conference presentations → Use technical language - Regulatory submission documents → Use formal FDA/EMA formats - Internal R&D team communications → Use full scientific detail - Patent applications → Use precise legal/scientific terminology - Patient-facing materials → Use `lay-summary-gen` **Integration:** - **Upstream**: `market-access-value` (commercial assessment), `competitor-trial-monitor` (competitive landscape) - **Downstream**: `business-model-canvas` (strategy development), `investor-relations-prep` (ongoing communications) ## Core Capabilities ### 1. Science-to-Business Translation Convert technical concepts into investor-friendly language: ```python from scripts.narrative_engine import BiotechNarrativeEngine engine = BiotechNarrativeEngine() # Translate technical description translation = engine.translate_science( technical_description=""" Our proprietary AAV9-based gene therapy utilizes a codon-optimized transgene under control of a liver-specific promoter to restore functional enzyme in patients with MPS I deficiency. """, audience="generalist_vc", preserve_accuracy=True ) print(translation.business_narrative) # "One-time gene therapy delivering a functional copy of the missing enzyme, # potentially curing MPS I rather than managing symptoms" ``` **Translation Strategies:** | Technical Concept | Business Translation | Why It Works | |-------------------|---------------------|--------------| | "CRISPR-Cas9 gene editing" | "Precision genetic medicine platform" | Platform implies scalability | | "Phase II clinical data" | "De-risked asset with human proof-of-concept" | Reduces perceived risk | | "Off-target effects" | "Industry-leading specificity profile" | Competitive framing | | "MOA via JAK-STAT pathway" | "Novel mechanism addressing root cause" | Value proposition | ### 2. Narrative Architecture Structure pitch deck flow for maximum impact: ```python # Generate complete narrative arc narrative = engine.build_narrative( company_stage="series_b", science_type="gene_therapy", clinical_stage="phase_2", target_market="rare_disease", key_differentiation="one_time_cure" ) # Access each component print(narrative.hook) # Opening grab print(narrative.problem) # Market pain point print(narrative.solution) # Your approach print(narrative.traction) # Validation to date print(narrative.ask) # Funding request ``` **Narrative Structure:** 1. **Hook** (30 seconds): Why this, why now, why you 2. **Problem** ($B+ market): Unmet medical need, current standard limitations 3. **Solution**: Your technology/platform, mechanism of action 4. **Traction**: Clinical data, partnerships, validation 5. **Market**: Size, competition, your advantage 6. **Team**: Track record, why you'll succeed 7. **Ask**: Funding amount, use of proceeds, milestones ### 3. Stage-Specific Optimization Calibrate message depth for funding round: ```python # Optimize for different stages seed_narrative = engine.optimize_for_stage( base_narrative=narrative, stage="seed", focus="team_and_vision" # Seed cares about team and big idea ) series_a_narrative = engine.optimize_for_stage( base_narrative=narrative, stage="series_a", focus="proof_of_concept" # Series A needs validation ) ipo_narrative = engine.optimize_for_stage( base_narrative=narrative, stage="ipo", focus="commercial_readiness" # IPO requires near-term revenue ) ``` **Stage Requirements:** | Stage | Key Questions | Focus Areas | |-------|---------------|-------------| | **Seed** ($500K-$2M) | Can you execute? | Team, vision, early validation | | **Series A** ($10-30M) | Does it work? | POC data, IP position, market entry | | **Series B** ($30-75M) | Will it scale? | Phase 2/3 data, BD traction, team expansion | | **Series C/IPO** ($100M+) | Commercial execution | Registration trials, launch prep, revenue path | ### 4. Investor Audience Calibration Adapt tone and depth for different investor types: ```python # Calibrate for specific investor calibrated = engine.calibrate_for_audience( narrative=narrative, investor_type="healthcare_vc", # vs "generalist_vc" or "pharma_corp" technical_depth="moderate", # Depth of scientific detail risk_tolerance="high" # Early vs late stage framing ) ``` **Investor Types:** - **Generalist VC**: Focus on market size, business model, team pedigree - **Healthcare VC**: Balance science rigor with commercial potential - **Pharma BD**: Emphasize strategic fit, validation data, partnership potential - **Public Market**: Highlight near-term catalysts, revenue projections, risk mitigation ## Common Patterns ### Pattern 1: Clinical-Stage Therapeutics **Scenario**: Phase 2 biotech raising Series B. ```bash # Generate complete pitch narrative python scripts/main.py \ --science "Small molecule inhibitor targeting mutant KRAS G12C" \ --stage "phase_2" \ --indication "lung_cancer" \ --data "ORR 45%, median PFS 6.5 months" \ --competition "Mirati, J&J" \ --output series_b_narrative.json ``` **Narrative Elements:** - **Problem**: KRAS mutations in 30% of cancers; previously "undruggable" - **Solution**: First-in-class covalent inhibitor with superior selectivity - **Traction**: Phase 2 data showing 45% response rate, durable responses - **Market**: $15B+ opportunity across multiple tumor types - **Differentiation**: Best-in-class potency, favorable safety profile - **Ask**: $75M to complete Phase 3 and prepare NDA ### Pattern 2: Platform Company **Scenario**: Novel delivery platform company raising seed. ```python platform_narrative = engine.generate_platform_narrative( platform_technology="Lipid nanoparticle for CNS delivery", differentiator="Crosses BBB with 50x improvement over existing LNPs", applications=["Alzheimer's", "Parkinson's", "brain_cancer"], stage="seed", target="platform_value_creation" ) ``` **Platform Story Arc:** - **Platform Thesis**: Solving delivery problem unlocks multiple indications - **Validation**: Proof-of-mechanism in 2+ disease models - **Breadth**: Pipeline across CNS, oncology, rare disease - **Partnership Appeal": Pharma interest in accessing CNS targets - **Scalability**: Manufacturing platform supports multiple assets ### Pattern 3: MedTech Device **Scenario**: Surgical robotics company Series A. ```python device_narrative = engine.generate_device_narrative( device_type="surgical_robot", clinical_benefit="50% reduction in complications, 30% faster recovery", regulatory_path="510k_de_novo", reimbursement="CPT_code_established", stage="series_a" ) ``` **Device-Specific Elements:** - **Clinical Evidence**: Superior outcomes vs. standard of care - **Economic Value**: Cost savings to healthcare system - **Regulatory Clarity**: Clear FDA pathway, reimbursement strategy - **Adoption Strategy**: Training, support, key opinion leader engagement ### Pattern 4: Pharma Partnership Pitch **Scenario**: Out-licensing asset to big pharma. ```bash # Generate BD materials python scripts/main.py \ --mode partnership \ --asset "Phase 2 ready asset" \ --indication "NASH" \ --data_package "Phase 1b complete, biomarker validated" \ --partner_profile "novo_nordisk" \ --output bd_presentation.json ``` **Partnership Framing:** - **Strategic Fit**: Complements partner's metabolism franchise - **Validation**: De-risked with human proof-of-mechanism - **Value Creation**: $500M+ peak sales potential - **Deal Structure**: Flexible partnership terms proposed ## Complete Workflow Example **Building comprehensive fundraising materials:** ```python from scripts.narrative_engine import BiotechNarrativeEngine from scripts.slide_generator import SlideGenerator from scripts.qa_prep import QAPreparation # Initialize engine = BiotechNarrativeEngine() slides = SlideGenerator() qa = QAPreparation() # Step 1: Generate core narrative narrative = engine.build_narrative( company_stage="series_a", therapeutic_area="oncology", modality="cell_therapy", clinical_stage="phase_1", key_differentiation="allogeneic_off_the_shelf" ) # Step 2: Create slide-by-slide guidance slide_guide = slides.generate_guide( narrative=narrative, n_slides=12, include_visual_suggestions=True ) # Step 3: Prepare Q&A qa_prep = qa.generate_qa( narrative=narrative, investor_type="healthcare_vc", depth="comprehensive" ) # Step 4: Export complete package engine.export_package( narrative=narrative, slides=slide_guide, qa=qa_prep, output_dir="series_a_pitch_package/" ) ``` ## Quality Checklist **Narrative Quality:** - [ ] Opening hook grabs attention in 30 seconds - [ ] Problem is a $B+ market with clear unmet need - [ ] Solution is differentiated vs. competition - [ ] Traction validates technical and commercial hypotheses - [ ] Team has relevant track record - [ ] Ask is specific with clear milestones **Translation Accuracy:** - [ ] Scientific claims remain accurate after simplification - [ ] No misleading statements or exaggerated claims - [ ] Risk factors disclosed appropriately - [ ] Regulatory pathway is realistic - [ ] Market size assumptions are defensible **Investor Alignment:** - [ ] Appropriate for stage and investor type - [ ] Addresses likely investor concerns proactively - [ ] Financial projections are reasonable - [ ] Exit strategy is credible **Before Presentation:** - [ ] **CRITICAL**: Legal review of all claims - [ ] **CRITICAL**: Scientific accuracy check by domain expert - [ ] Rehearsed with feedback from experienced biotech investors - [ ] Backup slides prepared for detailed questions ## Common Pitfalls **Translation Errors:** - ❌ **Oversimplification** → "Our drug cures cancer" (misleading) - ✅ "Our drug showed tumor shrinkage in 40% of patients" - ❌ **Jargon overload** → Technical terms without explanation - ✅ Use analogies: "Like a molecular GPS guiding drugs to tumors" - ❌ **Hiding risks** → No mention of side effects or competition - ✅ Acknowledge risks with mitigation strategies **Narrative Mistakes:** - ❌ **Technology in search of problem** → Cool science, no market - ✅ Start with problem, solution follows naturally - ❌ **Ignoring competition** → "We have no competitors" - ✅ Acknowledge competition, explain differentiation - ❌ **Unrealistic projections** → $10B revenue in Year 3 - ✅ Conservative estimates with clear assumptions **Stage Mismatch:** - ❌ **Seed deck with Phase 3 projections** → Too far ahead - ✅ Match milestones to stage-appropriate timelines - ❌ **IPO presentation to seed investors** → Wrong focus - ✅ Tailor depth and emphasis to investor sophistication ## References Available in `references/` directory: - `vc_presentation_best_practices.md` - Venture capital pitch guidelines - `biotech_valuation_models.md` - Valuation methodologies by stage - `regulatory_pathway_guides.md` - FDA/EMA approval timelines - `market_sizing_methodologies.md` - TAM/SAM/SOM calculations - `investor_question_bank.md` - Common Q&A by investor type - `competitive_landscape_templates.md` - Positioning frameworks ## Scripts Located in `scripts/` directory: - `main.py` - CLI interface for narrative generation - `narrative_engine.py` - Core story architecture - `science_translator.py` - Technical to business translation - `slide_generator.py` - Deck structure and visual guidance - `qa_preparation.py` - Investor Q&A preparation - `competitive_analyzer.py` - Market positioning analysis - `risk_framer.py` - Risk mitigation messaging - `stage_optimizer.py` - Funding round calibration ## Limitations - **Not Financial Advice**: Cannot provide investment recommendations - **Regulatory Compliance**: Does not ensure SEC or other regulatory compliance - **Market Specificity**: May not capture niche investor preferences - **Real-Time Adaptation**: Cannot adjust to live investor reactions - **Confidentiality**: Does not handle material non-public information protection - **Legal Review**: All materials require legal counsel review before use ## Parameters | Parameter | Type | Default | Required | Description | |-----------|------|---------|----------|-------------| | `--science` | string | - | Yes* | Scientific description of technology | | `--stage` | string | - | Yes* | Funding stage (pre-seed, seed, series-a, etc.) |